In patients with moderate peripheral artery disease, use of GLP-1 RAs increases the likelihood of more favorable cardiovascular and major limb outcomes.

A longtime vaccine critic hired by Health Secretary RFK Jr is reviewing safety data in an effort to revisit debunked claims that vaccines may cause autism.

The FDA has granted Fast Track designation to nadunolimab to treat patients with previously untreated metastatic pancreatic ductal adenocarcinoma.

By including information on suicidal thoughts and behaviors, clinicians can greatly improve predictive accuracy via machine learning.

Dr L’Erario discusses neurologic care for TGD patients, highlighting key challenges, best practices, & steps toward more inclusive treatment.